← Eichor
Study identifier: NCT04965298 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

Condition: Idiopathic Pulmonary Fibrosis  ·  Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust

PhasePhase 3
Planned participants298
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

IPF is a progressive scarring lung condition causing coughing and breathlessness. IPF patients often have reflux disease meaning stomach acid may be breathed into the lungs, potentially damaging them. Medicines which stop stomach acid production, proton pump inhibitors (PPIs), can be used to reduce reflux symptoms including heartburn. Some researchers suggest PPIs also reduce IPF progression. This research aims to see if IPF progresses slower if treated with PPIs. Based on the results, we will be able to recommend whether or not IPF patients should take PPIs. This trial will involve 298 IPF patients from approximately 37 UK hospitals. At the beginning of the study, we will ask patients to start performing weekly breathing tests at home using equipment provided, and ask those with a cough to use a device to count the number of times they cough in 24hours. We will ask them to answer two questions rating their coughing and breathlessness, and complete questionnaires on their coughing, IPF, sleep habits and general condition. People will be given a PPI, called lansoprazole, or dummy tablets, twice per day for 12 months. They will be given a leaflet telling them what to do about reflux symptoms. At the end of the study, we will repeat these tests and analyse the results. We will record any side effects people may get. If people suffer side effects, they can reduce the dose. People taking medicines that interact with PPIs or have other serious medical conditions won't be able to…

This description comes directly from the study's public registry record.

Talk to the study team

Emily Harvey  ·  01603 591224  ·  emily.harvey@uea.ac.uk

TIPAL team  ·  tipal@uea.ac.uk

Always discuss trial participation with your own doctor first.

Locations (57)

Norfolk and Norwich University Hospitals NHS Foundation TrustNorwich, Norfolk, United KingdomRecruiting
NHS GrampianAberdeen, United KingdomRecruiting
Northern Health and Social Care TrustAntrim, United KingdomRecruiting
Hampshire Hospitals NHS Foundation TrustBasingstoke, United KingdomCompleted
Royal United Hospitals Bath NHS Foundation TrustBath, United KingdomRecruiting
University Hospitals Birmingham NHS Foundation Trust (QEHB)Birmingham, United KingdomRecruiting
University Hospitals Birmingham NHS Foundation TrustBirmingham, United KingdomRecruiting
East Lancashire Hospitals NHS TrustBlackburn, United KingdomCompleted
Blackpool Teaching Hospitals NHS Foundation TrustBlackpool, United KingdomNot Yet Recruiting
North Bristol NHS TrustBristol, United KingdomCompleted
West Suffolk NHS Foundation TrustBury St Edmunds, United KingdomRecruiting
Royal Papworth Hospital NHS Foundation TrustCambridge, United KingdomRecruiting

+ 45 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04965298